Effects of a Supplement Containing Fucoidan on Basal Body Temperature

Hiroshima University

Status: Completed

Conditions: Low Basal Body Temperature

Treatments: Dietary Supplement: Placebo; Dietary Supplement: Supplement containing fucoidan, EPA, and DHA

Study type: Interventional

Funder types: Other

Identifiers

NCT01399216

eki-420

Details and patient eligibility

About

We aim to determine whether a supplement containing fucoidan isolated from Mekabu (sporophyll of Undaria pinnatifida), EPA, and DHA has effects of elevating basal body temperature in subjects with low basal body temperature.

Enrollment: 19 patients

Sex: Female

Ages: 55 to 70 years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• Postmenopausal women with basal body temperature < 36.0 ºC
• Healthy as based on medical history and physical examination
• Willing not to donate blood during the study
• Informed consent signed

Exclusion criteria

• Renal or hepatic dysfunction
• Heart disease
• Participation in any clinical trial within 90 days of the commencement of the trial
• Subjects who are taking medicines or functional food that may affect basal body temperature

Trial design

Primary purpose: Prevention

Allocation: Randomized

Interventional model: Crossover Assignment

Masking: Double Blind

---

19 participants in 2 patient groups, including a placebo group

Fucoidan supplement

Experimental group

Treatment:

Dietary Supplement: Supplement containing fucoidan, EPA, and DHA

Placebo

Placebo Comparator group

Treatment:

Dietary Supplement: Placebo